Literature DB >> 9922058

Three-year prospective adherence to three breast cancer screening modalities.

L J Solomon1, R M Mickey, C J Rairikar, J K Worden, B S Flynn.   

Abstract

BACKGROUND: This study prospectively examined rates of adherence to mammography, clinical breast examination (CBE), and breast self-examination (BSE) in a cohort of women over 3 years to determine whether participation in BSE influenced participation in the other two screening modalities.
METHODS: Women ages 51 and older (n = 450) who attended a small group educational session to learn BSE and to hear about CBE and mammography guidelines were assessed annually by telephone for 3 consecutive years to determine their subsequent breast cancer screening behavior.
RESULTS: Annual CBE and mammography screening are highly positively associated. Regular performance of BSE has a modest positive association with both CBE and mammography adherence over time.
CONCLUSIONS: Women who perform BSE regularly over time may be more likely to adhere to the other breast cancer screening guidelines.

Entities:  

Mesh:

Year:  1998        PMID: 9922058     DOI: 10.1006/pmed.1998.0357

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  3 in total

1.  The influence of breast self-examination on subsequent mammography participation.

Authors:  Susan E Jelinski; Colleen J Maxwell; Jay Onysko; Christina M Bancej
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

2.  Knowledge on risk factors and practice of early detection methods of breast cancer among graduating students of Debre Tabor University, Northcentral Ethiopia.

Authors:  Gashaw Mehiret; Amsalu Molla; Aragaw Tesfaw
Journal:  BMC Womens Health       Date:  2022-05-18       Impact factor: 2.742

3.  The transtheoretical model, health belief model, and breast cancer screening among Iranian women with a family history of breast cancer.

Authors:  Ziba Farajzadegan; Fariba Fathollahi-Dehkordi; Simin Hematti; Reza Sirous; Neda Tavakoli; Reza Rouzbahani
Journal:  J Res Med Sci       Date:  2016-11-07       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.